Single Oral Dose Study of Atovaquone/Proguanil Hydrochloride Combination Tablets and Atovaquone Suspension

NCT01858831 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Malaria

Interventions

DRUG: Atovaquone/proguanil HCL
DRUG: Atovaquone

Sponsor

GlaxoSmithKline